Conversely, hypocretin/orexin receptor antagonists promote sleep and cataplexy in narcoleptic mice (Black et al., 2013) and are used clinically to treat insomnia (Cox et al., 2010; Herring et al., 2012). The gene discussed is HCRT; the disease is Cataplexy.